Position in GPCR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,291,958
-$1,099,091 QoQ
Shares Held
47,551
-2.5% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pier Capital, LLC holds $20,446,999 across 6 Biotechnology names. GPCR ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
227,093 | $6,290,476 | |
| 2 | CYTK |
Cytokinetics Inc
|
69,583 | $4,586,215 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
101,304 | $3,899,190 | |
| 4 | GPCR |
Structure Therapeutics Inc.
This page
|
47,551 | $2,291,958 | |
| 5 | OLMA |
Olema Pharmaceuticals, Inc.
|
136,108 | $2,029,370 | |
| 6 | CAPR |
Capricor Therapeutics, Inc.
|
44,401 | $1,349,790 |
All Filings in GPCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,291,958 | 47,551 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,391,049 | 48,757 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $5,530,252 | 197,509 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,116,433 | 198,478 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,678,721 | 212,520 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,596,220 | 132,604 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $5,894,031 | 134,291 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,974,281 | 101,204 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $4,181,293 | 97,557 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,453,216 | 35,653 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||